America Great Health (AAGH) EV to EBITDA (2014 - 2024)

America Great Health has reported EV to EBITDA for 10 years, with the latest figure at 1577.21 in Q1 2024.

• On a quarterly basis, EV to EBITDA rose 16.4% year-over-year to 1577.21 in Q1 2024; TTM through Mar 2024 was 406.72, a 357.37% decrease from a year earlier, with the FY2023 full-year figure at 427.81, down 860.92% from the prior year.
• EV to EBITDA was 1577.21 for Q1 2024 at America Great Health, up from 2744.33 in the prior quarter.
• The five-year high for EV to EBITDA was 103.55 in Q2 2022, with the low at 171201.45 in Q3 2020.
• Average EV to EBITDA over 5 years is 26241.86, with a median of 2744.33 recorded in 2023.
• The sharpest annual moves came in 2020 and 2022: EV to EBITDA sank 2459.18% in 2020, then surged 99.54% in 2022.
• Over 5 years, EV to EBITDA stood at 23366.1 in 2020, then surged by 94.86% to 1201.85 in 2021, then sank by 84.39% to 2216.04 in 2022, then decreased by 23.84% to 2744.33 in 2023, then surged by 42.53% to 1577.21 in 2024.
• The last three EV to EBITDA figures came in at 1577.21 (Q1 2024), 2744.33 (Q4 2023), and 2814.64 (Q3 2023), per Business Quant data.